Literature DB >> 16752660

Pattern of presentation of tuberculosis and the hospital prevalence of tuberculosis and HIVco-infection in University College Hospital, Ibadan: a review of five years (1998 - 2002).

O M Ige1, O M Sogaolu, O A Ogunlade.   

Abstract

A 5-year review (1998-2002) was done at the pulmonary unit of the University College Hospital (UCH), Ibadan, Nigeria to determine the pattern of presentation of tuberculosis (TB) and the prevalence of TB and human Immunodefiency virus (HIV) co-infection. A total of one thousand patients were managed for TB but 777 confirmed as having TB had their case files analysed. There were 418 males and 359 females giving a male to female ratio of 1.16:1.00. Pulmonary tuberculosis (PTB) accounted for 78.6% of the patients seen over the period, followed by tuberculosis meningitis 7.8% then TB spine 6.8% and that of the lymph node 4.1%. The other types of TB (Abdomen, pericardial and miliary) accounted for less than 3%. The highest number of cases of tuberculosis (27.8%) was in the 20-29 age group for both male and female followed by those less than 40 years (26.0%). Less than 20% (18.3%) were 40 years old and above. The number of TB cases decreased sharply from a total of 188 in the year 2000 to 89 in 2002. The decrease in number was most likely due to the fact that directly observed therapy short course (DOTS) are now available at other centres within the city and its environs. Only 180 out of the 640 cases of TB were confirmed as HIV positive giving a seroprevalence rate of 28.12%. The annual distribution of TB/HIV co-infection showed a rising trend from 26 cases in 1998 to 42 cases in 2002.

Entities:  

Mesh:

Year:  2005        PMID: 16752660

Source DB:  PubMed          Journal:  Afr J Med Med Sci        ISSN: 0309-3913


  9 in total

1.  Epidemiology of smear - negative tuberculosis in ibadan, Nigeria.

Authors:  Oludiran Kehinde Aderemi; Hannah Dada-Adegbola
Journal:  Afr J Infect Dis       Date:  2013

2.  Lipid profile in HIV/AIDS patients in Nigeria.

Authors:  O O Adewole; S Eze; Ye Betiku; E Anteyi; I Wada; Z Ajuwon; G Erhabor
Journal:  Afr Health Sci       Date:  2010-06       Impact factor: 0.927

3.  Multidrug resistance to Mycobacterium tuberculosis in a tertiary hospital.

Authors:  Aderemi Oludiran Kehinde; Felix Ariebuwa Obaseki; Oluponle Christiana Ishola; Kolo Doko Ibrahim
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

4.  HIV testing, HIV status and outcomes of treatment for tuberculosis in a major diagnosis and treatment centre in Yaounde, Cameroon: a retrospective cohort study.

Authors:  Eric Walter Pefura Yone; Christopher Kuaban; André Pascal Kengne
Journal:  BMC Infect Dis       Date:  2012-08-15       Impact factor: 3.090

5.  Changes in Lipid Profiles and Other Biochemical Parameters in HIV-1 Infected Patients Newly Commenced on HAART Regimen.

Authors:  Ballah Akawu Denue; Mohammed Bashir Alkali; Ali Usman Abjah; Ibrahim Musa Kida; Babajide Ajayi; Bala Zira Fate
Journal:  Infect Dis (Auckl)       Date:  2013-03-06

6.  Tuberculous meningitis presenting with unusual clinical features in Nigerians: Two case reports.

Authors:  Morenikeji A Komolafe; Taofiki A Sunmonu; Olufunmi A Esan
Journal:  Cases J       Date:  2008-09-24

7.  Prevalence and predictors of tuberculosis coinfection among HIV-seropositive patients attending the Aminu Kano Teaching Hospital, northern Nigeria.

Authors:  Zubairu Iliyasu; Musa Babashani
Journal:  J Epidemiol       Date:  2009-03-06       Impact factor: 3.211

8.  Chromosomal rearrangements and protein globularity changes in Mycobacterium tuberculosis isolates from cerebrospinal fluid.

Authors:  Seow Hoon Saw; Joon Liang Tan; Xin Yue Chan; Kok Gan Chan; Yun Fong Ngeow
Journal:  PeerJ       Date:  2016-09-21       Impact factor: 2.984

9.  Isolation and Immunological Detection of Mycobacterium Tuberculosis from HIV and Non-HIV Patients in Benue State, Nigeria.

Authors:  Francis Enenche Ejeh; Ann Undiandeye; Kenneth Okon; Haruna Moshud Kazeem; Ayuba Caleb Kudi
Journal:  Ethiop J Health Sci       Date:  2020-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.